Comparatively, a study carried out in 196 patients who were part of the GENDEP (Genome-Based Therapeutic Drugs for Depression) study found a significant association between CYP2C19 and CYP2D6 genotype and steady state escitalopram concentrations (47). The gene discussed is CYP2C19; the disease is depressive disorder.